Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

This trial is testing whether a chemotherapy drug called gemcitabine, delivered as an inhaled mist (aerosol) directly into the lungs, is safe and effective for patients whose cancer has spread to the lungs. **You may be eligible if...** - You have a solid tumor (any type) that has spread to your lungs - There is no standard treatment known to cure or significantly extend your life - You are between 12 and 50 years old - Your blood counts, kidney, liver, and lung function are within acceptable ranges - Your lungs can hold at least 50% of their expected air capacity and your oxygen levels are normal without supplemental oxygen - You are able to carry out basic daily activities with only mild limitations - Any side effects from previous cancer treatments have mostly resolved - You have not received radiation therapy in the last 2 weeks **You may NOT be eligible if...** - You currently use bronchodilators (inhalers) or steroids for a breathing condition, or have active asthma - You are pregnant or breastfeeding - You have an active, uncontrolled infection - You have received certain other experimental treatments recently Talk to your doctor to see if this trial is right for you.